6 Hydroxydopamine,
6-Hydroxydopamine,
6-OHDA,
Hydrobromide, Oxidopamine,
Hydrochloride, Oxidopamine,
Oxidopamine,
Oxidopamine Hydrobromide,
Oxidopamine Hydrochloride,
6-Hydroxydopamine hydrobromide,
636-00-0,
Oxidopamine hydrobromide,
6-Hydroxydopamine hydrogen bromide,
6-hydroxydopamine hbr,
UNII-TWC1D4W0WB,
Oxidopamine (hydrobromide),
5-(2-aminoethyl)benzene-1,2,4-triol hydrobromide,
EINECS 211-247-0,
TWC1D4W0WB,
NSC 238469,
6-OH-DA,
2,4,5-Trihydroxyphenethylamine hydrobromide,
2,5-Dihydroxytyramine hydrobromide,
5-(2-Aminoethyl)-4-hydroxypyrocatechol hydrobromide,
MFCD00012894,
1,2,4-Benzenetriol, 5-(2-aminoethyl)-, hydrobromide,
2-(2,4,5-Trihydroxyphenyl)ethylamine hydrobromide,
MLS002207128,
SMR001306725,
6-HODA hydrobromide,
ACMC-1B4FQ,
AC1L41YS,
C8H11NO3.HBr,
SCHEMBL738049,
CHEMBL1718398,
CTK5B9541,
HY-B1081A,
AOB5529,
DTXSID30212972,
WLN: Z2R BQ DQ EQ &EH,
BCP25700,
6-Hydroxydopamine hydrobromide, 95%,
BN0710,
NSC238469,
AKOS015916618,
CHM0114828,
CS-5966,
MCULE-7480233859,
NSC-238469,
AS-40064,
LS-32262,
ST055651,
AX8109343,
DB-054509,
TC-168132,
B7099,
FT-0632700,
KS-00001832,
5-(2-aminoethyl)benzene-1,2,4-triol, bromide,
C-49683,
1,4-Benzenetriol, 5-(2-aminoethyl)-, hydrobromide,
5-(2-aminoethyl)-1,2,4-benzenetriol hydrobromide,
6-Hydroxydopamine hydrobromide, >=90% (HPLC), solid,
I14-51329,
6-HYDROXYDOPAMINE HYDROBROMIDE WITH ASCORBIC ACID,
1,2,4-Benzenetriol,5-(2-aminoethyl)-, hydrobromide (1:1),
6-Hydroxydopamine hydrobromide, contains ascorbic acid as stabilizer, >=98% (HPLC),
2-(2,4,5-TRIHYDROXYPHENYL)ETHYLAMINE HYDROBROMIDE 2,5-DIHYDROXYTYRAMINE HYDROBROMIDE 2,4,5-TRIHYDROXYPHENETHYLAMINE HYDROBROMIDE 6-,
oxidopamine,
6-OHDA,
6-HYDROXYDOPAMINE,
hydroxydopamine hydrobromide,
C8H11NO3.BrH,
C(CN)c1cc(O)c(O)cc1O,
C8-H11-N-O3.Br-H,
5-(2-Aminoethyl)-1,2,4-benzenetriol,
CID176170,